CVE-2025-23516: Brainvireinfo Sale With Razorpay
High severity, CVSS 7.1. EPSS: 0.3% chance of exploitation in the next 30 days.
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in brainvireinfo Sale with Razorpay sell-with-razorpay allows Reflected XSS.This issue affects Sale with Razorpay: from n/a through <= 1.0.
Affected products
- Brainvireinfo Sale With Razorpay: up to and including 1.0
Published 2025-03-03. Last modified 2026-06-17.